Patents by Inventor Dennis S. Charney

Dennis S. Charney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTRANNASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION
    Publication number: 20140256821
    Abstract: Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).
    Type: Application
    Filed: March 5, 2014
    Publication date: September 11, 2014
    Applicants: Icahn School of Medicine at Mount Sinai, National Institute of Health, Yale University School of Medicine
    Inventors: Dennis S. Charney, Sanjay J. Mathew, Husseini K. Manji, Carlos A. Zarate, John H. Krystal
  • Intranasal administration of ketamine to treat depression
    Patent number: 8785500
    Abstract: Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).
    Type: Grant
    Filed: March 20, 2007
    Date of Patent: July 22, 2014
    Assignees: Icahn School of Medicine at Mount Sinai, Yale University, National Institute of Health
    Inventors: Dennis S. Charney, Sanjay J. Mathew, Husseini K. Manji, Carlos A. Zarate, Jr., John H. Krystal
  • Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia
    Patent number: 5447948
    Abstract: Mazindol and other dopamine and/or noradrenergic reuptake inhibitors are effective to treat negative symptoms in schizophrenia.
    Type: Grant
    Filed: May 7, 1992
    Date of Patent: September 5, 1995
    Assignee: Yale University
    Inventors: John P. Seibyl, John H. Krystal, Dennis S. Charney